Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Icecure Medical Q2 EPS $(0.06) Beats $(0.07) Estimate, Sales $525.000K Miss $662.500K Estimate

Author: Benzinga Newsdesk | August 13, 2025 07:32am
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 7.69 percent. This is unchanged from the same period last year. The company reported quarterly sales of $525.000 thousand which missed the analyst consensus estimate of $662.500 thousand by 20.75 percent. This is a 48.07 percent decrease over sales of $1.011 million the same period last year.

Posted In: ICCM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist